News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major economic, corporate, or geopolitical headlines were published in the past hour, leaving markets without fresh catalysts.
  • US equity futures traded flat as investors awaited scheduled data releases and earnings reports.
  • Treasury yields were little changed amid thin news flow and steady Fed rate expectations.
  • Oil and gold prices showed muted movement on absence of new supply or demand developments.
  • Market volatility eased slightly with low trading volume and limited headline risk.

Latest Articles

Barclays Sees Small Earnings Impact from Potential ECB Reserve Hike

Barclays Sees Small Earnings Impact from Potential ECB Reserve Hike

Barclays analysts estimate that a hypothetical increase in the European Central Bank's minimum reserve requirement from 1% to 2% would have a modest effect on bank earnings and net interest income in 2027, but the firm regards such a policy move as unlikely. The ECB's discussions are at an early stage with a formal decision expected by autumn befor…

After Servers, Memory: Where the Next Major AI Trade Is Emerging

After Servers, Memory: Where the Next Major AI Trade Is Emerging

A rules-based AI stock selection strategy identified and captured outsized gains from two distinct corners of the AI infrastructure theme - GPU-dense servers and NAND memory. By following quantitative rankings and monthly rebalances, the strategy locked large profits in Super Micro Computer and SanDisk, then rotated capital as valuations and relati…

ZenaTech’s ZenaDrone Advances Defense Drone Portfolio with Initial IQ Sphere Prototype for Autonomous GPS-Denied Inspections, Surveillance and Reconnaissance Missions

ZenaTech’s ZenaDrone Advances Defense Drone Portfolio with Initial IQ Sphere Prototype for Autonomous GPS-Denied Inspections, Surveillance and Reconnaissance Missions

ZenaTech, Inc. announced that its subsidiary ZenaDrone is developing the IQ Sphere, a compact autonomous drone designed for defense ISR missions and commercial inspections in GPS-denied and confined environments. The platform enhances situational awareness for defense operations and critical infrastructure inspection, expanding ZenaTech's autonomou…

Glass House Brands Completes First International Hemp Sale

Glass House Brands Completes First International Hemp Sale

Glass House Brands Inc., a leading U.S. cannabis company, completed its first international sale of smokeable CBD biomass to Europe, originating from its Camarillo Farm in California. The company emphasized compliance with California regulations and positioned its production for potential federal Medicare reimbursable CBD programs. This milestone r…

MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)

MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)

MeiraGTx Holdings plc announced a strategic partnership with Oberland Capital Management for an investment of up to $400 million. The deal includes up to $375 million in non-dilutive capital and $25 million in equity to support the development and commercialization of key gene therapy programs targeting radiation-induced xerostomia (AAV2-hAQP1), X-…

Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026

Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026

Cytokinetics announced three late-breaking science presentations at the ESC Congress showcasing primary results from the pivotal Phase 3 ACACIA-HCM trial of aficamten in symptomatic non-obstructive hypertrophic cardiomyopathy (HCM) patients. The company plans to engage regulatory authorities following positive topline results and will host an inves…

Cornerstone First Mortgage Switches to nCino's Mortgage Point of Sale to Support Its Next Phase of Growth

Cornerstone First Mortgage Switches to nCino's Mortgage Point of Sale to Support Its Next Phase of Growth

nCino, Inc. announced that Cornerstone First Mortgage has switched to using nCino's Mortgage Point of Sale platform to support its rapid growth and improve borrower experiences across its 49-state branch network. The platform's flexibility and AI-driven capabilities enable Cornerstone to streamline the loan process through digital verifications and…

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Acumen Pharmaceuticals announced it will present three studies at the Alzheimer's Association International Conference 2026, showcasing progress in its Enhanced Brain Delivery (EBD) technology developed with JCR Pharmaceuticals and patient-centric research from its ALTITUDE-AD Phase 2 trial. These studies emphasize advancements in targeting toxic a…

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™

BriaCell Therapeutics Corp. has engaged Charles River Associates and Kaleio to evaluate commercial strategy, brand planning, and market access potential for Bria-IMT, currently in a pivotal Phase 3 trial for metastatic breast cancer. These steps show proactive preparation for potential future commercialization, subject to regulatory approval and su…

Streamex Corp. Announces 10,000,000 Share Repurchase Program

Streamex Corp. Announces 10,000,000 Share Repurchase Program

Streamex Corp., a technology and infrastructure company specializing in tokenization of commodity real-world assets, announced a board-authorized share repurchase program to buy back up to 10 million shares at prices up to $2.00 per share within the next year. The program reflects the company's confidence in its intrinsic value and long-term growth…

Israeli Airstrikes Kill Two Palestinians in Gaza, Medics Say

Israeli Airstrikes Kill Two Palestinians in Gaza, Medics Say

Israeli strikes on Tuesday killed at least two Palestinians in the Gaza Strip, Gaza health officials and medics said. One strike in the Mawasi area of Khan Younis killed a man and wounded two children, while a later strike near a tent encampment for displaced families killed another person and injured five. The Israeli military said it targeted a H…

Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy

Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy

Alterity Therapeutics received official FDA End-of-Phase 2 meeting minutes confirming agreement on the Phase 3 clinical trial design for ATH434 in Multiple System Atrophy (MSA). The FDA agreed that a single pivotal Phase 3 trial supported by confirmatory evidence from prior Phase 2 trials could underpin potential drug approval, with trial initiatio…

Gilat Receives $11 Million in U.S. Department of War Orders, Reinforcing Role in Mission-Critical Defense Connectivity

Gilat Receives $11 Million in U.S. Department of War Orders, Reinforcing Role in Mission-Critical Defense Connectivity

Gilat Satellite Networks' subsidiary, Gilat DataPath, received $11 million in orders from the U.S. Department of War to supply custom SATCOM terminals and field services, highlighting the company's expanding footprint in mission-critical defense communication solutions. Deliveries are expected over the coming 12 months, underlining Gilat Defense's …

RBC Raises Tesla Price Target, Factors in Possible SpaceX Transaction

RBC Raises Tesla Price Target, Factors in Possible SpaceX Transaction

RBC Capital elevated its Tesla price target to $500 from $475 in a note on Tuesday, adding a premium tied to a potential combination with SpaceX while also revising the electric vehicle maker's standalone intrinsic value and segment forecasts. The update incorporates an assumed acquisition scenario reported in unconfirmed media accounts and includ…

Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement

Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement

Tvardi Therapeutics announced positive Phase 1 trial results for its novel oral STAT3 inhibitor, TTI-109, demonstrating rapid prodrug conversion to TTI-101, improved tolerability compared to the parent compound, and significant reductions in STAT3-driven immune cell populations. The company plans to advance TTI-109 into dermatologic and gastrointes…